Bente Lund

20002019
If you made any changes in Pure these will be visible here soon.

Fingerprint The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.

  • 20 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Platinum Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Placebos Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Dive into details by clicking on the dots.

Research Output 2000 2019

  • 21 Journal article
  • 13 Conference abstract in journal
  • 2 Poster
  • 1 Conference article in Journal

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

PRIMA/ENGOT-OV26/GOG-3012 Investigators, González-Martín, A., Pothuri, B., Vergote, I., DePont Christensen, R., Graybill, W., Mirza, M. R., McCormick, C., Lorusso, D., Hoskins, P., Freyer, G., Baumann, K., Jardon, K., Redondo, A., Moore, R. G., Vulsteke, C., O'Cearbhaill, R. E., Lund, B., Backes, F., Barretina-Ginesta, P. & 11 others, Haggerty, A. F., Rubio-Pérez, M. J., Shahin, M. S., Mangili, G., Bradley, W. H., Bruchim, I., Sun, K., Malinowska, I. A., Li, Y., Gupta, D. & Monk, B. J., 28 Sep 2019, In : The New England Journal of Medicine.

Research output: Contribution to journalJournal articleResearchpeer-review

Ovarian Neoplasms
Disease-Free Survival
Platinum
Homologous Recombination
Placebos

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

Del Campo, J. M., Matulonis, U. A., Malander, S., Provencher, D., Mahner, S., Follana, P., Waters, J., Berek, J. S., Woie, K., Oza, A. M., Canzler, U., Gil-Martin, M., Lesoin, A., Monk, B. J., Lund, B., Gilbert, L., Wenham, R. M., Benigno, B., Arora, S., Hazard, S. J. & 1 others, Mirza, M. R., 7 Jun 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 10 p.

Research output: Contribution to journalJournal articleResearchpeer-review

Platinum
Ovarian Neoplasms
Drug Therapy
Germ-Line Mutation
Therapeutics
1 Citation (Scopus)

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

Mirza, M. R., Åvall Lundqvist, E., Birrer, M. J., dePont Christensen, R., Nyvang, G-B., Malander, S., Anttila, M., Werner, T. L., Lund, B., Lindahl, G., Hietanen, S., Peen, U., Dimoula, M., Roed, H., Ør Knudsen, A., Staff, S., Krog Vistisen, A., Bjørge, L., Mäenpää, J. U., AVANOVA investigators & 1 others, Lund, B., Oct 2019, In : The Lancet. Oncology. 20, 10, p. 1409-1419 11 p.

Research output: Contribution to journalJournal articleResearchpeer-review

Platinum
Ovarian Neoplasms
Disease-Free Survival
Drug Therapy
Therapeutics

A time without symptoms or toxicity analysis of niraparib compared with routine surveillance in the maintenance treatment of patients with recurrent ovarian cancer

Mirza, M. R., Walder, L., Monk, B. J., Tinker, A. V., Mahner, S., Gil-Martin, M., Kalbacher, E., Waters, J., Wenham, R. M., Malander, S., Gilbert, L., Sehouli, J., Casado Herraez, A., Hardy-Bessard, AC., Williams, SJ., Rimel, BJ., Lund, B., Levy, T., Guy, H. & Matulonis, U. A., 2018. 1 p.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

A time without symptoms or toxicity analysis of niraparib compared with routine surveillance in the maintenance treatment of patients with recurrent ovarian cancer

Mirza, M. R., Walder, L., Monk, B. J., Tinker, A. V., Mahner, S., Gil-Martin, M., Kalbacher, E., Waters, J., Wenham, R. M., Malander, S., Gilbert, L., Sehouli, J., Casado Herraez, A., Hardy-Bessard, A., Williams, S. J., Rimel, B. J., Lund, B., Levy, T., Guy, H. & Matulonis, U. A., Oct 2018, In : Value in Health. 21, Suppl. 3, p. S16 PCN7.

Research output: Contribution to journalConference abstract in journalResearchpeer-review